Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Microbiology|March 8, 2021
Improved <i>in vitro</i> Efficacy of Baloxavir Marboxil Against Influenza A Virus Infection by Combination Treatment With the MEK Inhibitor ATR-002Hazem Hamza, Mahmoud M Shehata, Ahmed Mostafa, et al.
Plos One|January 24, 2015
Efficient generation of recombinant influenza A viruses employing a new approach to overcome the genetic instability of HA segmentsAhmed Mostafa, Pumaree Kanrai, Henning Petersen, et al.
Journal of Virology|November 24, 2017
Inhibition of Cytosolic Phospholipase A<sub>2</sub>α Impairs an Early Step of Coronavirus Replication in Cell CultureChristin Müller, Martin Hardt, Dominik Schwudke, et al.
The Journal of General Virology|October 17, 2001
Conservation of coding potential and terminal sequences in four different isolates of Borna disease virusStephan Pleschka, Peter Staeheli, Jolanta Kolodziejek, et al.
Journal of Virology|August 27, 2010
NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host responseZhongfang Wang, Nicole C Robb, Eva Lenz, et al.
Virology Journal|December 7, 2007
Higher polymerase activity of a human influenza virus enhances activation of the hemagglutinin-induced Raf/MEK/ERK signal cascadeHenju Marjuki, Hui-Ling Yen, John Franks, et al.
Antiviral Research|June 7, 2011
Inhibition of influenza virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus titers and cytokine expression simultaneously in vitro and in vivoRuth Pinto, Susanne Herold, Lidija Cakarova, et al.
Cellular Microbiology|August 3, 2006
Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defenceChristina Ehrhardt, Henju Marjuki, Thorsten Wolff, et al.
Molecular Biotechnology|May 13, 2006
An inducible T7 RNA polymerase-dependent plasmid systemMatthias Hamdorf, Heide Muckenfuss, Ulrich Tschulena, et al.
Antiviral Research|April 6, 2017
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivoEmanuel Haasbach, Christin Müller, Christina Ehrhardt, et al.
Pageof 10